Acid blockers may complicate pancreatic necrosis recovery, new trial investigates
NCT ID NCT07488299
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study looks at whether giving patients acid-reducing drugs (proton pump inhibitors) after an endoscopic procedure to drain pancreatic walled-off necrosis affects how many additional procedures they need. About 120 adults with this condition will be randomly assigned to receive the drug or not. The goal is to see if the drug increases the number of treatments needed and impacts complications, hospital stay, and costs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC WALLED-OFF NECROSIS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250063, China